


All 50 States Reach $7.4 Billion Settlement with Purdue Pharma Over Opioid Crisis
All 50 U.S. states have agreed to a $7.4 billion settlement with Purdue Pharma to address the opioid crisis, funding addiction treatment and prevention programs.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedHave an account? Sign in
Overview
- All 50 U.S. states, Washington, D.C., and four territories have agreed to a $7.4 billion settlement with Purdue Pharma over opioid-related lawsuits.
- The Sackler family, owners of Purdue Pharma, will contribute up to $7 billion over 15 years as part of the settlement agreement.
- A judge is being requested to advance the settlement to allow local governments and victims to vote on it after state support.
- The settlement aims to allocate funds to state and local governments to combat the addiction and overdose crisis in the U.S.
- This settlement represents one of the largest in a decade, reflecting a unified effort to address the opioid epidemic.
Report issue

Read both sides in 5 minutes each day
Analysis
Emphasizes all 50 U.S. states' support for Purdue Pharma's $7 billion opioid settlement plan.
Articles (6)
Center (4)
FAQ
The Sackler family will pay $1.5 billion, and Purdue Pharma will pay approximately $900 million in the first year.
The funds will be allocated to support addiction treatment, prevention, and recovery services across the U.S.
This settlement is one of the largest efforts to address the opioid epidemic, marking a unified endeavor to combat addiction and overdose across the U.S.
History
- 3M3 articles